A single-dose chimeric Newcastle disease virus (NDV)/chikungunya virus (CHIKV) is an effective CHIKV vaccine candidate
A Newcastle disease virus (NDV) vector vaccine candidate expressing the complete envelope (E3–E1) protein of chikungunya virus (CHIKV) successfully develops a novel vaccine candidate that utilizes Newcastle disease virus as a vector to express CHIKV antigens.